Group One Trading’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,050
| Closed | -$4.75K | – | 7832 |
|
|
2025
Q4 | $4.75K | Sell |
1,050
-13,268
| -93% | -$68K | ﹤0.01% | 7204 |
|
|
2025
Q3 | $77.2K | Buy |
14,318
+10,434
| +269% | +$56.5K | ﹤0.01% | 5572 |
|
|
2025
Q2 | $21.1K | Buy |
+3,884
| New | +$15.4K | ﹤0.01% | 6230 |
|
|
2025
Q1 | – | Sell |
-15,945
| Closed | -$55.5K | – | 7718 |
|
|
2024
Q4 | $54.4K | Sell |
15,945
-19,765
| -55% | -$57K | ﹤0.01% | 4993 |
|
|
2024
Q3 | $105K | Sell |
35,710
-43,650
| -55% | -$144K | ﹤0.01% | 4137 |
|
|
2024
Q2 | $270K | Buy |
79,360
+41,553
| +110% | +$136K | ﹤0.01% | 3140 |
|
|
2024
Q1 | $115K | Sell |
37,807
-15,200
| -29% | -$53.4K | ﹤0.01% | 4042 |
|
|
2023
Q4 | $223K | Buy |
53,007
+6,096
| +13% | +$33.1K | ﹤0.01% | 3770 |
|
|
2023
Q3 | $320K | Sell |
46,911
-58
| -0.1% | -$512 | ﹤0.01% | 3367 |
|
|
2023
Q2 | $489K | Buy |
46,969
+7,911
| +20% | +$70.8K | ﹤0.01% | 3044 |
|
|
2023
Q1 | $272K | Sell |
39,058
-10,501
| -21% | -$91.5K | ﹤0.01% | 3381 |
|
|
2022
Q4 | $299K | Buy |
49,559
+1,280
| +3% | +$9.46K | ﹤0.01% | 3499 |
|
|
2022
Q3 | $380K | Sell |
48,279
-875
| -2% | -$10.2K | ﹤0.01% | 3498 |
|
|
2022
Q2 | $669K | Sell |
49,154
-64,457
| -57% | -$1.07M | ﹤0.01% | 3160 |
|
|
2022
Q1 | $2.23M | Sell |
113,611
-18,248
| -14% | -$364K | ﹤0.01% | 2293 |
|
|
2021
Q4 | $4.52M | Sell |
131,859
-84,154
| -39% | -$3.39M | ﹤0.01% | 1796 |
|
|
2021
Q3 | $11.8M | Buy |
+216,013
| New | +$13M | 0.01% | 949 |
|
|
2021
Q2 | – | Sell |
-79,300
| Closed | -$7.93M | – | 8212 |
|
|
2021
Q1 | $7.25M | Buy |
79,300
+61,387
| +343% | +$5.96M | 0.01% | 1204 |
|
|
2020
Q4 | $1.45M | Buy |
+17,913
| New | +$1.37M | ﹤0.01% | 2309 |
|
Group One Trading's CVAC Position: Q1 2026 in Review
Group One Trading sold out of CureVac (CVAC) in Q1 2026, closing a stake of 1,050 shares — an estimated $4.75K sold.
Group One Trading first reported a position in CVAC in Q4 2020 and held it in 19 quarters. The position peaked at $11.8M in Q3 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Group One Trading reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 1,050 CureVac shares in Q1 2026, an estimated $4.75K.
- Group One Trading first reported a position in CureVac in Q4 2020 and held it in 19 quarters.
- Group One Trading's CureVac position peaked at $11.8M in Q3 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.